$50,365,175
OBSERVATIONAL ANTIRETROVIRAL STUDIES IN SOUTHERN AFRICA (OASIS) COLLABORATION
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funds observational research on antiretroviral treatments for HIV in Southern Africa through international collaboration.
Addresses HIV treatment outcomes in high-burden regions and generates real-world evidence to improve global public health responses.
Supports demand for antiretroviral drugs and diagnostic infrastructure in Southern African healthcare systems.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.001981.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_U01AI069924_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.